Conduit Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: CDTTW · Form: 8-K · Filed: May 6, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Conduit Pharma (formerly Murphy Canyon) filed an 8-K for shareholder votes. Keep an eye on what they're voting on.
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K on May 5, 2025, reporting on matters submitted to a vote of its security holders. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates that Conduit Pharmaceuticals is engaging in corporate actions requiring shareholder approval, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters submitted for a shareholder vote, not an event that inherently increases risk.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- May 5, 2025 (date) — Date of earliest event reported
- November 30, 2021 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific matters were submitted to a vote of Conduit Pharmaceuticals Inc. security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders,' but the specific details of these matters are not provided in the excerpt.
When was Conduit Pharmaceuticals Inc. formerly known as Murphy Canyon Acquisition Corp.?
The company was formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Conduit Pharmaceuticals Inc.
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
What is the fiscal year end for Conduit Pharmaceuticals Inc.?
The fiscal year end for Conduit Pharmaceuticals Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).